Previous 10 | Next 10 |
The stock market has dipped about 2% over the past week. Despite big gains, many expect the year to end strong due to positive seasonality. Investors should consider buying UPS, CNI, AVTR, GPC, and DBX. The stock market has been on a relentless rise and has been making new, all-time highs...
Avantor® to Present at the 39th Annual J.P. Morgan Healthcare Conference RADNOR, Pa. , Dec. 14, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced tech...
Halvorsen's 13F portfolio value increased from $23.14B to $27.68B. The number of positions increased 71 to 86. Viking Global increased Microsoft, Mecadolibre, and CME Group while reducing Amazon.com and dropping Uber Technologies & JD.com. The top three positions are Microsoft...
Our proprietary POWR Ratings rates stocks based on various measures. The ratings are calculated on a daily basis to provide investors an evaluation of stocks. The following four stocks were just upgraded to a "Buy" or "strong Buy" Charles Schwab Corporation (SCHW), Paccar (PCAR), Wipro (WIT),...
Avantor® to Participate at the Evercore ISI 3rd Annual HealthCONx Virtual Conference PR Newswire RADNOR, Pa., Nov. 23, 2020 RADNOR, Pa. , Nov. 23, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical product...
Dan Loeb's 13F portfolio value increased from ~$7.30B to ~$10B this quarter. The number of positions increased from 36 to 47. Third Point added PG&E while dropping Baxter International and Raytheon Technologies during the quarter. The top three positions are at ~22% of the por...
Cytosorbents has given investors +126% upside YTD on the back of top-line volumes driven by CytoSorb sales. Although impressive, we believe the portfolio is overexposed to Covid-19, and the concentration risk is only mitigated by pipeline movements in this segment. Management have...
Avantor® Opens New Biorepository Facility in Europe to Support Growing Demand for Scientific Research and Clinical Trial Sample Storage State-of-the-art facility near Frankfurt, Germany expands Avantor's geographic reach Investment supports globalization and increasing ...
Avantor has had a stellar year, leveraging their diverse portfolio to retain recurring revenue over the 3rd quarter. Each segment of the portfolio remains exposed less than 3%, whilst allowing exposure to COVID-19-related tailwinds. Shareholders have enjoyed +67% upside YTD, and b...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week aheadInvestors are likely to continue to hedge their bets between growth vs. value and vaccine plays vs. COVID shutdowns in th...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 07:15:06 ET Barclays analyst issues OVERWEIGHT recommendation for AVTR on July 29, 2024 05:42AM ET. The previous analyst recommendation was Overweight. AVTR was trading at $25.6 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...
Avantor® Reports Second Quarter 2024 Results PR Newswire Net sales of $1.70 billion , decrease of 2.4%; organic decline of 2.0% Net income of $93 million ; Adjusted EBITDA of $306 million Diluted GAAP EPS of $0.14 ; adjusted EPS of $0.25 Op...